Home > Articles > Health > Vision > Preclinical Data Suggests Quark's Eye Drug Candidate May Treat Glaucoma

Preclinical Data Suggests Quark's Eye Drug Candidate May Treat Glaucoma

Featured on: GenomeWeb Daily News
Publication date: Jul 27, 2009

Quark Pharmaceuticals, in collaboration with BioSpring, has announced the success of preclinical studies into a drug to prevent progressive retinal ganglion cell loss in an increased ocular-pressure rat model of glaucoma. The drug QPI-1007 showed positive results and a New drug application is expected.

Read Full Article

More Vision Articles

Breakthrough Medical Device Gives Hope For Blindness-Related Diseases
Contact Lens Safety News
Contact Lenses Can Be Implanted In The Eye
MP Claims Success In Campaign For Blind People
Behind The Scenes: Altered Visions
The Pros And Cons And Other Things To Look Out For
Optomostrist Focuses On Kids Squinting At Their Computer Screens
5 Summer Eye Safety Tips
Neurological Diseases Major Discovery
No Limit To The Benefits Of Eating Fruits And Vegetables

Not a member? Join now. Membership is free and packed with perks.

Chatterbean's Mission
Our free quizzes are fun to take while you take a break from work or during your free time, but they can also help you learn more about your personality, your lifestyle, and your health. Whether you stop by our site to take a personality quiz, IQ quiz, parenting quiz, love and sex quiz, health quiz, beauty and style quiz, or to create your own quiz, we aim to make you smile.

The material on this site is for informational purposes only, and is intended as a supplement, not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. More.

Polls on this site are for entertainment purposes only and are not scientific. Chatterbean is not responsible for the opinions expressed in polls.